Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)

Clinical trial NCT04959344 · COMPLETED

Trial details

NCT number: NCT04959344
Sponsor: LimmaTech Biologics AG
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Klebsiella Pneumoniae Infection

Start date: 2021-07-05
Primary completion: 2022-09-26
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.